Insulet Trial Demonstrates Meaningful Glycemic Improvements with Automated Insulin Delivery

 

• First randomized controlled trial to evaluate direct transition from multiple daily injections to automated insulin delivery in adults and children with type 1 diabetes who were not meeting glycemic targets with injections

• People using Omnipod 5 had significantly improved HbA1c levels (average reduction of -0.8%) compared with those using multiple daily injections with a continuous glucose monitor at the end of the three-month study period

• Omnipod 5 was also linked to dramatic improvements in glucose with people spending an average of +5.4 hours more per day with glucose levels in the target range without an increase in hypoglycemia

• https://finance.yahoo.com/news/insulet-radiant-trial-demonstrates-meaningful-200100768.html